Pieris napi chromosome 15, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997709.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
radial spoke head protein 3 homolog, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
radial spoke head protein 3 homolog, transcript variant X3
radial spoke head protein 3 homolog, transcript variant X1
radial spoke head protein 3 homolog isoform X2
radial spoke head protein 3 homolog B isoform X1
radial spoke head protein 3 homolog isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125056409, transcript variant X1
uncharacterized LOC125056405, transcript variant X3
uncharacterized LOC125056405, transcript variant X1
uncharacterized LOC125056405, transcript variant X2
uncharacterized LOC125056409, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
uncharacterized protein LOC125056839 isoform X1
putative uncharacterized protein DDB_G0282133 isoform X2
odorant receptor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
odorant receptor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable serine/threonine-protein kinase dyrk2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC125056818 isoform X2
MATH and LRR domain-containing protein PFE0570w-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125056810, transcript variant X2
uncharacterized LOC125056810, transcript variant X1
uncharacterized LOC125056811, transcript variant X1
uncharacterized LOC125056811, transcript variant X2
proline-rich extensin-like protein EPR1, transcript variant X1
proline-rich extensin-like protein EPR1, transcript variant X2
proline-rich extensin-like protein EPR1, transcript variant X3
proline-rich extensin-like protein EPR1 isoform X1
proline-rich extensin-like protein EPR1 isoform X2
proline-rich extensin-like protein EPR1 isoform X3
arrestin domain-containing protein F-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
arrestin domain-containing protein F-like, transcript variant X2
uncharacterized protein LOC125056790 isoform X2
arrestin domain-containing protein F-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 92 samples with support for all annotated introns
juvenile hormone esterase-like, transcript variant X1
juvenile hormone esterase-like, transcript variant X2
juvenile hormone esterase-like isoform X2
juvenile hormone esterase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
basic helix-loop-helix neural transcription factor TAP
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tubulin alpha-8 chain-like, transcript variant X1
tubulin alpha-8 chain-like, transcript variant X2
tubulin alpha-8 chain-like, transcript variant X3
uncharacterized protein ZK1073.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X7
uncharacterized protein ZK1073.1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X4
uncharacterized protein ZK1073.1, transcript variant X1
uncharacterized protein ZK1073.1, transcript variant X12
uncharacterized protein ZK1073.1, transcript variant X11
uncharacterized protein ZK1073.1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
uncharacterized protein ZK1073.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein ZK1073.1 isoform X10
uncharacterized protein ZK1073.1 isoform X9
uncharacterized protein ZK1073.1 isoform X8
uncharacterized protein ZK1073.1 isoform X7
uncharacterized protein ZK1073.1 isoform X6
uncharacterized protein ZK1073.1 isoform X4
uncharacterized protein ZK1073.1 isoform X5
uncharacterized protein ZK1073.1 isoform X2
uncharacterized protein ZK1073.1 isoform X3
uncharacterized protein ZK1073.1 isoform X1
uncharacterized protein ZK1073.1 isoform X12
uncharacterized protein ZK1073.1 isoform X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rap1 GTPase-GDP dissociation stimulator 1-B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 130 samples with support for all annotated introns
uncharacterized LOC125056490, transcript variant X1
uncharacterized LOC125056490, transcript variant X2
uncharacterized protein LOC125056490 isoform X1
uncharacterized protein LOC125056490 isoform X2
uncharacterized LOC125056604, transcript variant X2
uncharacterized protein LOC125056604 isoform X2
uncharacterized LOC125056604, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 98 samples with support for all annotated introns
uncharacterized protein LOC125056604 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
glutamate receptor-interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glutamate receptor-interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X1
glutamate receptor-interacting protein 2 isoform X2
uncharacterized LOC125056608, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC125056608, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 143 samples with support for all annotated introns
uncharacterized LOC125056608, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 146 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
inducible metalloproteinase inhibitor protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
uncharacterized LOC125056741, transcript variant X5
uncharacterized LOC125056741, transcript variant X1
uncharacterized LOC125056741, transcript variant X4
uncharacterized LOC125056741, transcript variant X6
uncharacterized LOC125056741, transcript variant X3
uncharacterized LOC125056741, transcript variant X2
uncharacterized protein LOC125056741 isoform X1
uncharacterized protein LOC125056741 isoform X3
uncharacterized protein LOC125056741 isoform X5
uncharacterized protein LOC125056741 isoform X2
uncharacterized protein LOC125056741 isoform X4
elongation of very long chain fatty acids protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
elongation of very long chain fatty acids protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
elongation of very long chain fatty acids protein-like
elongation of very long chain fatty acids protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 108 samples with support for all annotated introns
uncharacterized protein LOC125056792 isoform X2
elongation of very long chain fatty acids protein-like isoform X1
elongation of very long chain fatty acids protein 7-like, transcript variant X2
elongation of very long chain fatty acids protein 7-like, transcript variant X1
elongation of very long chain fatty acids protein 7-like, transcript variant X3
elongation of very long chain fatty acids protein 7-like
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X2
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X1
elongation of very long chain fatty acids protein AAEL008004-like isoform X2
elongation of very long chain fatty acids protein AAEL008004-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
elongation of very long chain fatty acids protein AAEL008004-like
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 117 samples with support for all annotated introns
inducible metalloproteinase inhibitor protein-like, transcript variant X2
inducible metalloproteinase inhibitor protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
inducible metalloproteinase inhibitor protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 153 samples with support for all annotated introns
inducible metalloproteinase inhibitor protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
inducible metalloproteinase inhibitor protein-like isoform X2
inducible metalloproteinase inhibitor protein-like isoform X1
inducible metalloproteinase inhibitor protein-like isoform X3
inducible metalloproteinase inhibitor protein-like isoform X4
probable RNA-binding protein 46, transcript variant X1
probable RNA-binding protein 46, transcript variant X3
probable RNA-binding protein 46, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
probable RNA-binding protein 46 isoform X3
probable RNA-binding protein 46 isoform X1
probable RNA-binding protein 46 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
myb/SANT-like DNA-binding domain-containing protein 3
cardioacceleratory peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC125056764, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125056764, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized LOC125056706, transcript variant X1
uncharacterized LOC125056706, transcript variant X2
uncharacterized protein LOC125056706 isoform X1
uncharacterized protein LOC125056706 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125056939, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125056939, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125056939 isoform X1
uncharacterized protein LOC125056939 isoform X2
peroxisomal targeting signal 2 receptor, transcript variant X2
peroxisomal targeting signal 2 receptor, transcript variant X1
activating signal cointegrator 1 complex subunit 2 homolog, transcript variant X1
activating signal cointegrator 1 complex subunit 2 homolog, transcript variant X2
activating signal cointegrator 1 complex subunit 2 homolog isoform X1
activating signal cointegrator 1 complex subunit 2 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
uncharacterized LOC125056564, transcript variant X2
uncharacterized LOC125056564, transcript variant X3
uncharacterized LOC125056564, transcript variant X1
uncharacterized protein LOC125056564 isoform X1
uncharacterized LOC125056564, transcript variant X4
uncharacterized protein LOC125056564 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
dual specificity protein phosphatase 14, transcript variant X2
dual specificity protein phosphatase 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
MAP kinase-interacting serine/threonine-protein kinase 1-like
E3 ubiquitin-protein ligase Hakai, transcript variant X2
E3 ubiquitin-protein ligase Hakai, transcript variant X1
E3 ubiquitin-protein ligase Hakai isoform X1
E3 ubiquitin-protein ligase Hakai isoform X2
NAD(P)H-hydrate epimerase, transcript variant X1
NAD(P)H-hydrate epimerase, transcript variant X2
zinc finger and BTB domain-containing protein 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17 isoform X2
zinc finger and BTB domain-containing protein 17 isoform X1
zinc finger and BTB domain-containing protein 17 isoform X3
kinesin-like protein KIF18A, transcript variant X2
kinesin-like protein KIF18A, transcript variant X3
kinesin-like protein KIF18A, transcript variant X1
FAD synthase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
FAD synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
leucine-rich repeat-containing protein 74A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
signal recognition particle subunit SRP72
probable rRNA-processing protein EBP2 homolog
uncharacterized LOC125056360, transcript variant X1
uncharacterized LOC125056360, transcript variant X2
transcription factor cwo, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
transcription factor cwo, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 142 samples with support for all annotated introns
uncharacterized LOC125056799, transcript variant X2
uncharacterized LOC125056799, transcript variant X1
uncharacterized LOC125056797, transcript variant X1
uncharacterized LOC125056797, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125056478, transcript variant X3
uncharacterized LOC125056478, transcript variant X4
uncharacterized LOC125056478, transcript variant X1
uncharacterized LOC125056478, transcript variant X2
uncharacterized protein LOC125056478 isoform X2
uncharacterized protein LOC125056478 isoform X1
elongation of very long chain fatty acids protein 5-like
LMBR1 domain-containing protein 2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 155 samples with support for all annotated introns
LMBR1 domain-containing protein 2 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
LMBR1 domain-containing protein 2 homolog isoform X1
LMBR1 domain-containing protein 2 homolog isoform X2
proteasome-associated protein ECM29 homolog
E3 ubiquitin-protein ligase NRDP1, transcript variant X1
E3 ubiquitin-protein ligase NRDP1, transcript variant X2
E3 ubiquitin-protein ligase NRDP1 isoform X2
E3 ubiquitin-protein ligase NRDP1 isoform X1
cyclin-G-associated kinase, transcript variant X1
cyclin-G-associated kinase, transcript variant X3
cyclin-G-associated kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
uncharacterized LOC125056758, transcript variant X1
uncharacterized LOC125056758, transcript variant X2
uncharacterized protein LOC125056758 isoform X2
uncharacterized protein LOC125056758 isoform X1
uncharacterized LOC125056588, transcript variant X2
uncharacterized LOC125056588, transcript variant X1
uncharacterized LOC125056588, transcript variant X6
uncharacterized LOC125056588, transcript variant X5
uncharacterized LOC125056588, transcript variant X3
uncharacterized LOC125056588, transcript variant X4
uncharacterized protein LOC125056588 isoform X1
uncharacterized protein LOC125056588 isoform X2
tudor domain-containing protein 1-like, transcript variant X2
tudor domain-containing protein 1-like, transcript variant X1
tudor domain-containing protein 1-like isoform X2
tudor domain-containing protein 1-like isoform X1
homeobox protein unc-4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
homeobox protein unc-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
homeobox protein unc-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 133 samples with support for all annotated introns
uncharacterized LOC125056860, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized LOC125056860, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
uncharacterized protein LOC125056860 isoform X1
uncharacterized protein LOC125056860 isoform X2
zinc-type alcohol dehydrogenase-like protein SERP1785
breast cancer anti-estrogen resistance protein 1, transcript variant X2
breast cancer anti-estrogen resistance protein 1 isoform X2
breast cancer anti-estrogen resistance protein 1, transcript variant X4
breast cancer anti-estrogen resistance protein 1, transcript variant X3
breast cancer anti-estrogen resistance protein 1 isoform X3
breast cancer anti-estrogen resistance protein 1, transcript variant X5
breast cancer anti-estrogen resistance protein 1, transcript variant X1
breast cancer anti-estrogen resistance protein 1 isoform X1
breast cancer anti-estrogen resistance protein 1 isoform X4
uncharacterized LOC125056383, transcript variant X2
uncharacterized LOC125056383, transcript variant X1
uncharacterized LOC125056383, transcript variant X3
uncharacterized protein LOC125056383 isoform X2
uncharacterized protein LOC125056383 isoform X1
uncharacterized LOC125056384, transcript variant X1
uncharacterized LOC125056384, transcript variant X2
uncharacterized LOC125056687, transcript variant X2
uncharacterized LOC125056687, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
dual specificity protein phosphatase 22-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dual specificity protein phosphatase 22-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dual specificity protein phosphatase 22-like isoform X2
dual specificity protein phosphatase 22-A-like isoform X1
transmembrane protein 184B, transcript variant X1
transmembrane protein 184B, transcript variant X2
mpv17-like protein 2, transcript variant X1
mpv17-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
sodium/hydrogen exchanger 3, transcript variant X1
sodium/hydrogen exchanger 3, transcript variant X8
sodium/hydrogen exchanger 3, transcript variant X9
sodium/hydrogen exchanger 3, transcript variant X2
sodium/hydrogen exchanger 3, transcript variant X6
sodium/hydrogen exchanger 3, transcript variant X4
sodium/hydrogen exchanger 3, transcript variant X7
sodium/hydrogen exchanger 3, transcript variant X3
sodium/hydrogen exchanger 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 16A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 118 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16A isoform X1
protein phosphatase 1 regulatory subunit 16A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
palmitoyl-protein thioesterase 1, transcript variant X1
palmitoyl-protein thioesterase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
chitooligosaccharidolytic beta-N-acetylglucosaminidase
MAPK regulated corepressor interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
2-oxoglutarate and iron-dependent oxygenase JMJD4
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
repressor of RNA polymerase III transcription MAF1 homolog
ATP synthase mitochondrial F1 complex assembly factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
growth hormone-inducible transmembrane protein-like
E3 ubiquitin-protein ligase lubel-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
E3 ubiquitin-protein ligase lubel-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
E3 ubiquitin-protein ligase lubel-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
E3 ubiquitin-protein ligase lubel-like isoform X1
E3 ubiquitin-protein ligase lubel-like isoform X2
small nuclear ribonucleoprotein-associated protein B
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
general transcription factor IIF subunit 2, transcript variant X1
general transcription factor IIF subunit 2, transcript variant X2
general transcription factor IIF subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
transport and Golgi organization protein 6
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X3
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X1
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X2
ubiquitin-conjugating enzyme E2Q-like protein CG4502 isoform X2
ubiquitin-conjugating enzyme E2Q-like protein CG4502 isoform X1
solute carrier family 66 member 2, transcript variant X3
solute carrier family 66 member 2, transcript variant X2
solute carrier family 66 member 2, transcript variant X1
solute carrier family 66 member 2 isoform X3
solute carrier family 66 member 2 isoform X2
solute carrier family 66 member 2 isoform X1
solute carrier family 66 member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
solute carrier family 66 member 2 isoform X6
solute carrier family 66 member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 142 samples with support for all annotated introns
solute carrier family 66 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
solute carrier family 66 member 2 isoform X5
solute carrier family 66 member 2 isoform X4
transmembrane protein 231-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 231-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 231-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
transmembrane protein 231-like isoform X2
transmembrane protein 231-like isoform X1
transmembrane protein 231-like isoform X3
mitochondrial import inner membrane translocase subunit Tim21
hemocyte protein-glutamine gamma-glutamyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
T-box transcription factor TBX20-like, transcript variant X2
T-box transcription factor TBX20-like, transcript variant X1
T-box transcription factor TBX20-like isoform X2
T-box transcription factor TBX20-like isoform X1
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X1
NADH-ubiquinone oxidoreductase 49 kDa subunit-like
large neutral amino acids transporter small subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
large neutral amino acids transporter small subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
large neutral amino acids transporter small subunit 1
39S ribosomal protein L10, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125056720, transcript variant X1
uncharacterized LOC125056720, transcript variant X2
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 homolog
platelet-activating factor acetylhydrolase IB subunit beta homolog, transcript variant X1
platelet-activating factor acetylhydrolase IB subunit beta homolog, transcript variant X2
platelet-activating factor acetylhydrolase IB subunit beta homolog isoform X2
platelet-activating factor acetylhydrolase IB subunit beta homolog isoform X1
uncharacterized LOC125056924, transcript variant X5
uncharacterized LOC125056924, transcript variant X4
uncharacterized LOC125056924, transcript variant X1
uncharacterized LOC125056924, transcript variant X6
uncharacterized LOC125056924, transcript variant X2
uncharacterized LOC125056924, transcript variant X3
lysine--tRNA ligase, transcript variant X2
lysine--tRNA ligase, transcript variant X1
uncharacterized LOC125056882, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC125056882, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125056882, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125056882, transcript variant X1
uncharacterized LOC125056882, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC125056882 isoform X2
uncharacterized protein LOC125056882 isoform X4
uncharacterized protein LOC125056882 isoform X1
uncharacterized protein LOC125056882 isoform X3
uncharacterized LOC125056883, transcript variant X1
uncharacterized LOC125056883, transcript variant X3
uncharacterized LOC125056883, transcript variant X5
uncharacterized LOC125056883, transcript variant X2
uncharacterized LOC125056883, transcript variant X4
uncharacterized LOC125056903, transcript variant X2
uncharacterized LOC125056903, transcript variant X1
uncharacterized protein LOC125056903 isoform X2
uncharacterized protein LOC125056903 isoform X1
uncharacterized protein LOC125056883 isoform X2
uncharacterized protein LOC125056883 isoform X1
eukaryotic initiation factor 4A, transcript variant X2
eukaryotic initiation factor 4A, transcript variant X1
uncharacterized LOC125056900, transcript variant X1
uncharacterized LOC125056900, transcript variant X3
uncharacterized LOC125056900, transcript variant X2
uncharacterized protein LOC125056900 isoform X1
uncharacterized protein LOC125056900 isoform X2
activating signal cointegrator 1 complex subunit 1, transcript variant X3
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1 isoform X3
activating signal cointegrator 1 complex subunit 1 isoform X2
activating signal cointegrator 1 complex subunit 1 isoform X1
activating signal cointegrator 1 complex subunit 1, transcript variant X4
activating signal cointegrator 1 complex subunit 1 isoform X4
schwannomin-interacting protein 1 homolog, transcript variant X2
schwannomin-interacting protein 1 homolog, transcript variant X3
schwannomin-interacting protein 1 homolog, transcript variant X4
schwannomin-interacting protein 1 homolog, transcript variant X1
schwannomin-interacting protein 1 homolog isoform X1
schwannomin-interacting protein 1 homolog isoform X2
schwannomin-interacting protein 1 homolog isoform X3
transmembrane 9 superfamily member 4, transcript variant X1
transmembrane 9 superfamily member 4, transcript variant X2
transmembrane 9 superfamily member 4 isoform X1
transmembrane 9 superfamily member 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
radial spoke head 10 homolog B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
radial spoke head 10 homolog B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
radial spoke head 10 homolog B-like, transcript variant X3
radial spoke head 10 homolog B-like isoform X1
radial spoke head 10 homolog B-like isoform X2
radial spoke head 10 homolog B-like, transcript variant X4
radial spoke head 10 homolog B-like isoform X3
radial spoke head 10 homolog B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125056890 isoform X4
CDK5 and ABL1 enzyme substrate 2, transcript variant X2
CDK5 and ABL1 enzyme substrate 2, transcript variant X3
CDK5 and ABL1 enzyme substrate 2, transcript variant X1
CDK5 and ABL1 enzyme substrate 2 isoform X2
CDK5 and ABL1 enzyme substrate 2 isoform X3
CDK5 and ABL1 enzyme substrate 2 isoform X1
E3 ubiquitin-protein ligase MIB1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 97 samples with support for all annotated introns
WW domain-containing oxidoreductase-like, transcript variant X2
WW domain-containing oxidoreductase-like, transcript variant X1
WW domain-containing oxidoreductase-like isoform X1
WW domain-containing oxidoreductase-like isoform X2
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16
succinate dehydrogenase assembly factor 4, mitochondrial-like
conserved oligomeric Golgi complex subunit 6
39S ribosomal protein L15, mitochondrial
adenosylhomocysteinase, transcript variant X1
adenosylhomocysteinase, transcript variant X2
adenosylhomocysteinase, transcript variant X4
adenosylhomocysteinase, transcript variant X5
adenosylhomocysteinase, transcript variant X3
adenosylhomocysteinase, transcript variant X6
adenosylhomocysteinase, transcript variant X7
importin subunit beta-1, transcript variant X2
importin subunit beta-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125056919
major facilitator superfamily domain-containing protein 1-like, transcript variant X1
major facilitator superfamily domain-containing protein 1-like isoform X1
major facilitator superfamily domain-containing protein 1-like, transcript variant X2
major facilitator superfamily domain-containing protein 1-like isoform X2
carcinine transporter, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
carcinine transporter, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
carcinine transporter, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC125056888 isoform X2
probable palmitoyltransferase ZDHHC24, transcript variant X1
probable palmitoyltransferase ZDHHC24, transcript variant X2
trifunctional enzyme subunit alpha, mitochondrial
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like isoform X1
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like isoform X2
BTB/POZ domain-containing protein 6-like
uncharacterized LOC125056686, transcript variant X1
uncharacterized LOC125056686, transcript variant X2
uncharacterized protein LOC125056686 isoform X1
uncharacterized protein LOC125056686 isoform X2
vacuolar protein sorting-associated protein 52 homolog, transcript variant X1
vacuolar protein sorting-associated protein 52 homolog isoform X1
vacuolar protein sorting-associated protein 52 homolog, transcript variant X2
vacuolar protein sorting-associated protein 52 homolog isoform X2
5'-AMP-activated protein kinase subunit gamma-like, transcript variant X1
5'-AMP-activated protein kinase subunit gamma-like, transcript variant X3
5'-AMP-activated protein kinase subunit gamma-like, transcript variant X2
5'-AMP-activated protein kinase subunit gamma-like
uncharacterized LOC125056694, transcript variant X2
uncharacterized LOC125056694, transcript variant X1
chitin synthase chs-2, transcript variant X4
chitin synthase chs-2, transcript variant X3
chitin synthase chs-2, transcript variant X2
chitin synthase chs-2, transcript variant X1
suppressor APC domain-containing protein 2
28S ribosomal protein S18b, mitochondrial, transcript variant X2
28S ribosomal protein S18b, mitochondrial, transcript variant X1
uncharacterized protein LOC125056956 isoform X2
28S ribosomal protein S18b, mitochondrial isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X1
uncharacterized protein C18orf63-like, transcript variant X1
uncharacterized protein C18orf63-like, transcript variant X2
uncharacterized protein C18orf63-like isoform X1
uncharacterized protein C18orf63-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2
transcription termination factor, mitochondrial, transcript variant X2
transcription termination factor, mitochondrial, transcript variant X1
transcription termination factor, mitochondrial isoform X1
transcription termination factor, mitochondrial isoform X2
cell division control protein 6 homolog, transcript variant X2
cell division control protein 6 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
dnaJ homolog subfamily C member 7, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X2
dnaJ homolog subfamily C member 7 isoform X1
dnaJ homolog subfamily C member 7 isoform X2
uncharacterized LOC125056981, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125056981, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC125056981 isoform X2
uncharacterized protein LOC125056981 isoform X1
coiled-coil domain-containing protein 25
uncharacterized LOC125056983, transcript variant X1
uncharacterized LOC125056983, transcript variant X2
uncharacterized protein LOC125056983 isoform X1
uncharacterized LOC125056983, transcript variant X3
uncharacterized protein LOC125056983 isoform X2
cAMP-dependent protein kinase catalytic subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
triple functional domain protein-like, transcript variant X1
triple functional domain protein-like, transcript variant X2
triple functional domain protein-like isoform X1
triple functional domain protein-like isoform X2
muscleblind-like protein, transcript variant X3
muscleblind-like protein, transcript variant X2
muscleblind-like protein, transcript variant X8
muscleblind-like protein, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
muscleblind-like protein, transcript variant X1
muscleblind-like protein, transcript variant X6
muscleblind-like protein, transcript variant X5
muscleblind-like protein, transcript variant X7
muscleblind-like protein, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
muscleblind-like protein, transcript variant X4
muscleblind-like protein, transcript variant X10
muscleblind-like protein, transcript variant X9
leucine-rich repeat extensin-like protein 5 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 143 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 139 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 159 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
CD109 antigen-like, transcript variant X2
CD109 antigen-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
enhancer of yellow 2 transcription factor-like
multiple epidermal growth factor-like domains protein 8, transcript variant X1
multiple epidermal growth factor-like domains protein 8, transcript variant X2
multiple epidermal growth factor-like domains protein 8 isoform X1
multiple epidermal growth factor-like domains protein 8 isoform X2
neural retina-specific leucine zipper protein-like
diacylglycerol O-acyltransferase 1, transcript variant X1
diacylglycerol O-acyltransferase 1, transcript variant X3
diacylglycerol O-acyltransferase 1, transcript variant X2
diacylglycerol O-acyltransferase 1, transcript variant X5
diacylglycerol O-acyltransferase 1, transcript variant X4
diacylglycerol O-acyltransferase 1 isoform X3
diacylglycerol O-acyltransferase 1 isoform X2
diacylglycerol O-acyltransferase 1 isoform X1
mediator of RNA polymerase II transcription subunit 11
COORDINATES: nucleotide motif:Rfam:12.0:RF01174
nuclear fragile X mental retardation-interacting protein 1
uncharacterized LOC125056598, transcript variant X1
uncharacterized LOC125056598, transcript variant X2
uncharacterized protein LOC125056598 isoform X1
uncharacterized protein LOC125056598 isoform X2
RNA 5'-monophosphate methyltransferase, transcript variant X2
RNA 5'-monophosphate methyltransferase, transcript variant X1
RNA 5'-monophosphate methyltransferase, transcript variant X3
uncharacterized LOC125056843, transcript variant X1
uncharacterized LOC125056843, transcript variant X2
uncharacterized protein LOC125056843 isoform X1
uncharacterized protein LOC125056843 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
homeotic protein spalt-major, transcript variant X1
homeotic protein spalt-major, transcript variant X2
homeotic protein spalt-major, transcript variant X3
homeotic protein spalt-major, transcript variant X4
26S proteasome non-ATPase regulatory subunit 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
geranylgeranyl transferase type-2 subunit alpha
uncharacterized protein C6orf132 homolog
dynein axonemal assembly factor 6, transcript variant X3
dynein axonemal assembly factor 6, transcript variant X2
probable 26S proteasome non-ATPase regulatory subunit 3
dynein axonemal assembly factor 6, transcript variant X1
dynein axonemal assembly factor 6 isoform X1
dynein axonemal assembly factor 6 isoform X2
protein phosphatase PHLPP-like protein, transcript variant X1
protein phosphatase PHLPP-like protein isoform X1
protein phosphatase PHLPP-like protein, transcript variant X2
protein phosphatase PHLPP-like protein isoform X2
protein phosphatase PHLPP-like protein, transcript variant X3
protein phosphatase PHLPP-like protein isoform X3
LIM/homeobox protein Lhx3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LIM/homeobox protein Lhx3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
3,4-dihydroxyphenylacetaldehyde synthase-like
transmembrane protein 268, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 143 samples with support for all annotated introns
transmembrane protein 268, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized protein LOC125056510 isoform X1
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
glycerophosphocholine phosphodiesterase GPCPD1 isoform X3
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X2
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X1
glycerophosphocholine phosphodiesterase GPCPD1 isoform X1
glycerophosphocholine phosphodiesterase GPCPD1 isoform X2
serine/threonine-protein phosphatase 1 regulatory subunit 10-like
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X1
serine/threonine-protein phosphatase 1 regulatory subunit 10 isoform X1
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X3
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X2
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X4
uncharacterized protein DDB_G0284459 isoform X3
uncharacterized protein DDB_G0284459 isoform X2
uncharacterized protein DDB_G0284459 isoform X4
FAD-dependent oxidoreductase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
sodium/hydrogen exchanger 9B2-like, transcript variant X3
sodium/hydrogen exchanger 9B2-like, transcript variant X4
sodium/hydrogen exchanger 9B2-like, transcript variant X1
sodium/hydrogen exchanger 9B2-like, transcript variant X2
sodium/hydrogen exchanger 9B1-like isoform X1
sodium/hydrogen exchanger 9B2-like isoform X2
sodium/hydrogen exchanger 9B1-like, transcript variant X2
sodium/hydrogen exchanger 9B1-like isoform X2
sodium/hydrogen exchanger 9B1-like, transcript variant X1
sodium/hydrogen exchanger 9B2-like isoform X1
sodium/hydrogen exchanger 9B2-like isoform X3
sodium/hydrogen exchanger 9B2-like, transcript variant X5
sodium/hydrogen exchanger 9B2-like isoform X4
G-protein coupled receptor Mth2, transcript variant X1
G-protein coupled receptor Mth2, transcript variant X2
G-protein coupled receptor Mth2 isoform X2
G-protein coupled receptor Mth2 isoform X1
RNA-binding protein 39, transcript variant X1
RNA-binding protein 39, transcript variant X2
RNA-binding protein 39, transcript variant X3
RNA-binding protein 39, transcript variant X4
RNA-binding protein 39, transcript variant X7
RNA-binding protein 39, transcript variant X5
RNA-binding protein 39, transcript variant X6
uncharacterized LOC125056475, transcript variant X2
uncharacterized LOC125056475, transcript variant X1
2',5'-phosphodiesterase 12, transcript variant X1
2',5'-phosphodiesterase 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein transport protein Sec61 subunit beta
adenylate cyclase type 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adenylate cyclase type 3, transcript variant X1
adenylate cyclase type 3, transcript variant X2
uncharacterized LOC125056937, transcript variant X2
uncharacterized LOC125056937, transcript variant X1
chitin deacetylase 1, transcript variant X2
chitin deacetylase 1, transcript variant X1
transcription termination factor 3, mitochondrial
endoplasmic reticulum-Golgi intermediate compartment protein 3
carnitine O-acetyltransferase-like, transcript variant X2
carnitine O-acetyltransferase-like, transcript variant X3
carnitine O-acetyltransferase-like, transcript variant X1
carnitine O-acetyltransferase-like isoform X1
carnitine O-acetyltransferase-like isoform X2
probable NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
myosin tail region-interacting protein MTI1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 7, transcript variant X2
chromodomain-helicase-DNA-binding protein 7, transcript variant X1
chromodomain-helicase-DNA-binding protein 7 isoform X2
chromodomain-helicase-DNA-binding protein 7 isoform X1
golgin subfamily A member 2-like, transcript variant X1
golgin subfamily A member 2-like, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1-like
GDP-fucose protein O-fucosyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
actin-related protein 2/3 complex subunit 5-B
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
EGF domain-specific O-linked N-acetylglucosamine transferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
transcription factor Dp-1, transcript variant X1
transcription factor Dp-1, transcript variant X2
transcription factor Dp-1, transcript variant X3
COP9 signalosome complex subunit 9, transcript variant X3
COP9 signalosome complex subunit 9, transcript variant X1
COP9 signalosome complex subunit 9, transcript variant X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
UPF0598 protein CG30010, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 164 samples with support for all annotated introns
UPF0598 protein CG30010, transcript variant X2
katanin p80 WD40 repeat-containing subunit B1, transcript variant X1
katanin p80 WD40 repeat-containing subunit B1, transcript variant X3
katanin p80 WD40 repeat-containing subunit B1, transcript variant X2
katanin p80 WD40 repeat-containing subunit B1 isoform X1
katanin p80 WD40 repeat-containing subunit B1 isoform X3
katanin p80 WD40 repeat-containing subunit B1 isoform X2
uncharacterized LOC125056560, transcript variant X1
uncharacterized LOC125056560, transcript variant X3
uncharacterized protein LOC125056560 isoform X1
uncharacterized protein LOC125056560 isoform X3
uncharacterized LOC125056560, transcript variant X2
uncharacterized protein LOC125056560 isoform X2
sodium leak channel NALCN, transcript variant X2
sodium leak channel NALCN, transcript variant X1
thioredoxin reductase-like selenoprotein T homolog CG3887
B9 domain-containing protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
B9 domain-containing protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
B9 domain-containing protein 2 isoform X1
B9 domain-containing protein 2 isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
anti-apoptotic protein NR13-like, transcript variant X2
anti-apoptotic protein NR13-like, transcript variant X1
anti-apoptotic protein NR13-like isoform X1
anti-apoptotic protein NR13-like isoform X2
uncharacterized LOC125056700, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 92 samples with support for all annotated introns
uncharacterized LOC125056700, transcript variant X1
ankyrin repeat domain-containing protein 39
rho guanine nucleotide exchange factor 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rho guanine nucleotide exchange factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
rho guanine nucleotide exchange factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
rho guanine nucleotide exchange factor 7, transcript variant X4
rho guanine nucleotide exchange factor 7, transcript variant X5
rho guanine nucleotide exchange factor 7, transcript variant X6
rho guanine nucleotide exchange factor 7 isoform X3
rho guanine nucleotide exchange factor 7 isoform X4
rho guanine nucleotide exchange factor 7 isoform X2
uncharacterized protein LOC125056959 isoform X1
homocysteine S-methyltransferase YbgG-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC125056842, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125056842, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC125056842 isoform X1
uncharacterized protein LOC125056842 isoform X2
transcription initiation factor TFIID subunit 5
uncharacterized LOC125056812, transcript variant X6
uncharacterized LOC125056812, transcript variant X7
uncharacterized protein LOC125056812 isoform X6
uncharacterized protein LOC125056812 isoform X7
uncharacterized LOC125056812, transcript variant X5
uncharacterized LOC125056812, transcript variant X1
uncharacterized LOC125056812, transcript variant X3
uncharacterized LOC125056812, transcript variant X2
uncharacterized LOC125056812, transcript variant X4
uncharacterized LOC125056812, transcript variant X8
uncharacterized protein LOC125056812 isoform X1
uncharacterized protein LOC125056812 isoform X3
uncharacterized protein LOC125056812 isoform X2
uncharacterized protein LOC125056812 isoform X5
uncharacterized protein LOC125056812 isoform X4
uncharacterized protein LOC125056812 isoform X8
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog isoform X2
nucleosome assembly protein 1-like 1, transcript variant X1
nucleosome assembly protein 1-like 1 isoform X1
nucleosome assembly protein 1-like 1, transcript variant X2
nucleosome assembly protein 1-like 1 isoform X2
RNA polymerase II-associated factor 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
carbonic anhydrase-related protein 10, transcript variant X2
carbonic anhydrase-related protein 10, transcript variant X1
carbonic anhydrase-related protein 10, transcript variant X3
carbonic anhydrase-related protein 10 isoform X2
carbonic anhydrase-related protein 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
alpha-(1,3)-fucosyltransferase C-like, transcript variant X2
alpha-(1,3)-fucosyltransferase C-like, transcript variant X1
alpha-(1,3)-fucosyltransferase C-like, transcript variant X3
alpha-(1,3)-fucosyltransferase C-like isoform X2
alpha-(1,3)-fucosyltransferase C-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
deoxycytidylate deaminase, transcript variant X2
deoxycytidylate deaminase, transcript variant X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit
uncharacterized LOC125056676, transcript variant X2
uncharacterized LOC125056676, transcript variant X1
uncharacterized protein LOC125056676 isoform X1
uncharacterized protein LOC125056676 isoform X2
BRCA2-interacting transcriptional repressor EMSY-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 163 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha, transcript variant X5
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X4
nuclear transcription factor Y subunit alpha, transcript variant X6
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha isoform X1
nuclear transcription factor Y subunit alpha isoform X3
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
homeodomain-interacting protein kinase 2, transcript variant X2
homeodomain-interacting protein kinase 2, transcript variant X1
homeodomain-interacting protein kinase 2, transcript variant X3
homeodomain-interacting protein kinase 2 isoform X1
homeodomain-interacting protein kinase 2 isoform X2
cyclin-dependent kinase inhibitor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 155 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
ras association domain-containing protein 10, transcript variant X1
ras association domain-containing protein 10, transcript variant X2
ras association domain-containing protein 10
proteasome subunit alpha type-1, transcript variant X2
proteasome subunit alpha type-1, transcript variant X1
proteasome subunit alpha type-1 isoform X2
proteasome subunit alpha type-1 isoform X1
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transient receptor potential protein, transcript variant X1
transient receptor potential protein, transcript variant X2
transient receptor potential protein isoform X1
transient receptor potential protein isoform X2
transient-receptor-potential-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transient-receptor-potential-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transient-receptor-potential-like protein isoform X1
transient-receptor-potential-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1 isoform X1
probable protein phosphatase 2C T23F11.1 isoform X3
probable protein phosphatase 2C T23F11.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1 isoform X2
probable protein phosphatase 2C T23F11.1 isoform X4
galactose mutarotase, transcript variant X4
galactose mutarotase, transcript variant X1
galactose mutarotase, transcript variant X2
galactose mutarotase, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X10
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X8
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X7
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X9
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X6
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X9
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X7
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X6
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X8
uncharacterized LOC125056817, transcript variant X1
uncharacterized LOC125056817, transcript variant X4
uncharacterized LOC125056817, transcript variant X3
uncharacterized LOC125056817, transcript variant X2
uncharacterized protein LOC125056817 isoform X1
uncharacterized protein LOC125056817 isoform X2
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X3
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X4
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X1
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X7
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X2
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X5
protein kinase C and casein kinase substrate in neurons protein 2, transcript variant X6
protein kinase C and casein kinase substrate in neurons protein 2 isoform X1
protein kinase C and casein kinase substrate in neurons protein 1 isoform X4
protein kinase C and casein kinase substrate in neurons protein 1 isoform X6
protein kinase C and casein kinase substrate in neurons protein 2 isoform X2
protein kinase C and casein kinase substrate in neurons protein 1 isoform X5
protein kinase C and casein kinase substrate in neurons protein 2 isoform X3
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
myotubularin-related protein 13, transcript variant X3
myotubularin-related protein 13, transcript variant X2
myotubularin-related protein 13, transcript variant X1
myotubularin-related protein 13 isoform X3
myotubularin-related protein 13 isoform X2
myotubularin-related protein 13 isoform X1
E3 ubiquitin-protein ligase UBR1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
E3 ubiquitin-protein ligase UBR1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
E3 ubiquitin-protein ligase UBR1 isoform X2
E3 ubiquitin-protein ligase UBR1 isoform X1
protein arginine methyltransferase NDUFAF7 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
probable ATP-dependent RNA helicase Dbp45A
myotubularin-related protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
myotubularin-related protein 8 isoform X2
myotubularin-related protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
myotubularin-related protein 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
amphoterin-induced protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
amphoterin-induced protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC125056504, transcript variant X2
uncharacterized LOC125056504, transcript variant X1
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X3
carboxypeptidase B-like, transcript variant X2
carboxypeptidase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 159 samples with support for all annotated introns
uncharacterized LOC125056691, transcript variant X1
uncharacterized LOC125056691, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125056497, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC125056497, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
apoptosis-inducing factor 1, mitochondrial-like, transcript variant X1
apoptosis-inducing factor 1, mitochondrial-like, transcript variant X2
apoptosis-inducing factor 1, mitochondrial-like isoform X2
apoptosis-inducing factor 1, mitochondrial-like isoform X1
uncharacterized LOC125056393, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 97 samples with support for all annotated introns
uncharacterized LOC125056393, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 139 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase
uncharacterized LOC125056446, transcript variant X1
uncharacterized LOC125056446, transcript variant X2
uncharacterized protein LOC125056446 isoform X1
uncharacterized protein LOC125056446 isoform X2
chymotrypsin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
chymotrypsin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
chymotrypsin-2-like, transcript variant X1
chymotrypsin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
chymotrypsin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
prothoracicostatic peptides-like, transcript variant X1
prothoracicostatic peptides-like, transcript variant X3
prothoracicostatic peptides-like, transcript variant X2
prothoracicostatic peptides-like isoform X1
prothoracicostatic peptide-like isoform X3
prothoracicostatic peptides-like isoform X2
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X6
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X2
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X1
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X4
tRNA:m(4)X modification enzyme TRM13 homolog isoform X1
tRNA:m(4)X modification enzyme TRM13 homolog isoform X5
tRNA:m(4)X modification enzyme TRM13 homolog isoform X4
tRNA:m(4)X modification enzyme TRM13 homolog isoform X2
tRNA:m(4)X modification enzyme TRM13 homolog isoform X3
ADP-ribosylation factor GTPase-activating protein 3
E3 ubiquitin-protein ligase TRIM33, transcript variant X1
E3 ubiquitin-protein ligase TRIM33, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription intermediary factor 1-alpha isoform X1
E3 ubiquitin-protein ligase TRIM33 isoform X2
glucosamine-6-phosphate isomerase, transcript variant X3
glucosamine-6-phosphate isomerase, transcript variant X1
glucosamine-6-phosphate isomerase, transcript variant X2
glucosamine-6-phosphate isomerase 2 isoform X3
glucosamine-6-phosphate isomerase isoform X1
glucosamine-6-phosphate isomerase isoform X2
glucosamine-6-phosphate isomerase, transcript variant X4
glucosamine-6-phosphate isomerase isoform X4
charged multivesicular body protein 2a, transcript variant X2
charged multivesicular body protein 2a, transcript variant X1
charged multivesicular body protein 2a, transcript variant X3
lysoplasmalogenase, transcript variant X2
lysoplasmalogenase, transcript variant X1
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X16
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X18
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X10
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X9
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X19
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X17
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X14
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X8
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X1
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X2
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X3
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X15
putative apoptosis-inducing factor 1, mitochondrial isoform X1
putative apoptosis-inducing factor 1, mitochondrial isoform X2
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X5
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X12
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X7
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X6
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X4
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X11
putative apoptosis-inducing factor 1, mitochondrial, transcript variant X13
putative apoptosis-inducing factor 1, mitochondrial isoform X3